Putnam Investments LLC Ascendis Pharma A/S Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Putnam Investments LLC holds 725,651 shares of ASND stock, worth $111 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
725,651
Previous 772,362
6.05%
Holding current value
$111 Million
Previous $72.3 Million
26.37%
% of portfolio
0.13%
Previous 0.11%
Shares
22 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.55 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$761 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$659 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$644 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$601 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.56B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...